169 related articles for article (PubMed ID: 22350005)
21. Dedifferentiated chondrosarcoma with rhabdomyosarcomatous differentiation.
Reith JD; Bauer TW; Fischler DF; Joyce MJ; Marks KE
Am J Surg Pathol; 1996 Mar; 20(3):293-8. PubMed ID: 8772782
[TBL] [Abstract][Full Text] [Related]
22. Dedifferentiated Central Chondrosarcoma: A Clinical, Histopathological, and Immunohistochemical Analysis of 57 Cases.
Gong LH; Su YB; Zhang W; Liu WF; Dong RF; Sun XQ; Zhang M; Ding Y
Front Med (Lausanne); 2021; 8():746909. PubMed ID: 34631758
[TBL] [Abstract][Full Text] [Related]
23. Co-expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in cartilaginous tumours: a marker for malignancy?
Kunisada T; Moseley JM; Slavin JL; Martin TJ; Choong PF
Pathology; 2002 Apr; 34(2):133-7. PubMed ID: 12009094
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
25. [TP53 gene aberrations in chondromatous neoplasms: correlation with immunohistochemical p53 accumulation and MDM2 expression].
Blasenbreu S; Baretton GB; Bender C; Haas CJ; Diebold J; Löhrs U
Verh Dtsch Ges Pathol; 1998; 82():284-9. PubMed ID: 10095448
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathologic diagnosis of de-differentiated chondrosarcoma].
Huang J; Zhang HZ; Zheng L; Zhou J; Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):820-3. PubMed ID: 20193457
[TBL] [Abstract][Full Text] [Related]
27. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.
Schrage YM; Lam S; Jochemsen AG; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Cell Mol Med; 2009 Sep; 13(9A):2843-52. PubMed ID: 18624751
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysis.
Zhang Y; Paz Mejia A; Temple HT; Trent J; Rosenberg AE
Hum Pathol; 2014 Jul; 45(7):1541-5. PubMed ID: 24792622
[TBL] [Abstract][Full Text] [Related]
29. Dedifferentiated peripheral chondrosarcomas. A report of seven cases.
Bertoni F; Present D; Bacchini P; Picci P; Pignatti G; Gherlinzoni F; Campanacci M
Cancer; 1989 May; 63(10):2054-9. PubMed ID: 2702574
[TBL] [Abstract][Full Text] [Related]
30. Secondary peripheral chondrosarcoma in multiple osteochondromas: a retrospective single-institution case series.
Gnoli M; Gambarotti M; Righi A; Staals EL; Evangelista A; Tremosini M; Brizola E; Mordenti M; Boarini M; Locatelli M; Pedrini E; Sangiorgi L
Orphanet J Rare Dis; 2024 Feb; 19(1):63. PubMed ID: 38351015
[TBL] [Abstract][Full Text] [Related]
31. Enchondroma protuberans. Report of a case and its distinction from chondrosarcoma and osteochondroma adjacent to an enchondroma.
Crim JR; Mirra JM
Skeletal Radiol; 1990; 19(6):431-4. PubMed ID: 2218592
[TBL] [Abstract][Full Text] [Related]
32. Dedifferentiated chondrosarcoma with muscle and cytokeratin differentiation in the anaplastic component.
Dervan PA; O'Loughlin J; Hurson BJ
Histopathology; 1988 May; 12(5):517-26. PubMed ID: 2456261
[TBL] [Abstract][Full Text] [Related]
33. Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency.
de Andrea CE; Zhu JF; Jin H; Bovée JV; Jones KB
J Pathol; 2015 Jun; 236(2):210-8. PubMed ID: 25644707
[TBL] [Abstract][Full Text] [Related]
34. Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis.
Lam SW; van Langevelde K; Suurmeijer AJH; Cleven AHG; Bovée JVMG
Histopathology; 2019 Dec; 75(6):843-852. PubMed ID: 31297850
[TBL] [Abstract][Full Text] [Related]
35. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
36. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma.
Meijer D; de Jong D; Pansuriya TC; van den Akker BE; Picci P; Szuhai K; Bovée JV
Genes Chromosomes Cancer; 2012 Oct; 51(10):899-909. PubMed ID: 22674453
[TBL] [Abstract][Full Text] [Related]
37. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract][Full Text] [Related]
38. p53 mutations in chondrosarcoma.
Terek RM; Healey JH; Garin-Chesa P; Mak S; Huvos A; Albino AP
Diagn Mol Pathol; 1998 Feb; 7(1):51-6. PubMed ID: 9646035
[TBL] [Abstract][Full Text] [Related]
39. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT?
Mosquera JM; Fletcher CD
Am J Surg Pathol; 2009 Sep; 33(9):1314-21. PubMed ID: 19718788
[TBL] [Abstract][Full Text] [Related]
40. Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes.
Bovée JV; Sciot R; Dal Cin P; Debiec-Rychter M; van Zelderen-Bhola SL; Cornelisse CJ; Hogendoorn PC
Diagn Mol Pathol; 2001 Dec; 10(4):228-35. PubMed ID: 11763313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
